4-氯-5-硝基-O-苯二胺 | 67073-39-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氯-5-硝基-O-苯二胺
• 中文别名: 4-氯-5-硝基邻苯二胺；4-氯-5-硝基-o-亚苯基二胺
• 英文名称: 4-chloro-5-nitrobenzene-1,2-diamine
• 英文别名: 4-chloro-5-nitro-1,2-phenylenediamine；4-nitro-5-chloro-1,2-phenylenediamine
• CAS: 67073-39-6
• 化学式: C₆H₆ClN₃O₂
• mdl: MFCD03427594
• 分子量: 187.586
• InChiKey: LOQLMWFVXRZASN-UHFFFAOYSA-N

物化性质

• 熔点：
  189-193 °C
• 沸点：
  458.9±40.0 °C(Predicted)
• 密度：
  1.592±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  97.9
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S36/37
• 危险类别码：
  R20/21/22
• 海关编码：
  2921590090
• 危险品运输编号：
  UN 2811
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P261,P280,P305+P351+P338,P311
• 危险性描述：
  H302+H312,H315,H319,H331,H335
• 储存条件：
  将药品存放于阴凉干燥处。

SDS

Name:	4-Chloro-5-Nitrophenylenediamine Material Safety Data Sheet
Synonym:	None Known
CAS:	67073-39-6

Section 1 - Chemical Product MSDS Name:4-Chloro-5-Nitrophenylenediamine Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
67073-39-6	4-Chloro-5-Nitrophenylenediamine	98.0%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
The toxicological properties of this substance have not been fully investigated.
Inhalation:
Harmful if inhaled. May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 67073-39-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: red
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 189-193 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H6ClN3O2
Molecular Weight: 187.5139

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not currently available.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 67073-39-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Chloro-5-Nitrophenylenediamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 67073-39-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 67073-39-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 67073-39-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氯-5-硝基-O-苯二胺 在 N,N-二异丙基乙胺 、 三氯氧磷 作用下， 以 四氢呋喃 为溶剂， 反应 40.5h， 生成 ethyl 1-(5-chloro-1-((2-methoxyethoxy)methyl)-6-nitro-1H-benzo[d]imidazol-2-yl)-1H-pyrazole-4-carboxylate
  参考文献：
  名称：

  [EN] BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS
  [FR] BENZOIMIDAZOLES COMME INHIBITEURS DE LA PROLYL HYDROXYLASE

  摘要：

  本发明涉及公式（1）的苯并咪唑化合物及其对映体、二对映体、消旋体和药学上可接受的盐。本发明的化合物在制药组合物和治疗由脯氨酸羟化酶活性调节的疾病状态、紊乱和条件的方法中是有用的。

  公开号：

  WO2009134750A1
• 作为产物：
  描述：

  1,3-二氯苯 在 sodium azide 、 硫酸 、 氢碘酸 、 potassium nitrate 作用下， 以 丙醇 为溶剂， 生成 4-氯-5-硝基-O-苯二胺
  参考文献：
  名称：

  The Preparation of 6,7-Disubstituted Quinoxalines¹

  摘要：

  DOI：

  10.1021/ja01494a030

文献信息

• [EN] AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS<br/>[FR] DÉRIVÉS AMINOPYRIMIDINIQUES UTILISÉS COMME MODULATEURS DE LRRK2
  申请人：HOFFMANN LA ROCHE

  公开号：WO2013079505A1

  公开（公告）日：2013-06-06

  Compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.

  式(I)的化合物或其药用可接受的盐，其中A、X、R1、R2、R3和R4如本文所定义。还公开了制备这些化合物的方法，并将这些化合物用于治疗与LRRK2受体相关的疾病，如帕金森病。
• Visible light promoted tandem dehydrogenation-deaminative cyclocondensation under aerobic conditions for the synthesis of 2-aryl benzimidazoles/quinoxalines from <i>ortho</i>-phenylenediamines and arylmethyl/ethyl amines
  作者：Firdoos Ahmad Sofi、Rohit Sharma、Ravi Rawat、Asit K. Chakraborti、Prasad V. Bharatam

  DOI：10.1039/d0nj03002c

  日期：——

  Visible light promoted domino synthesis of 2-aryl benzimidazoles is reported through the reaction of ortho-phenylenediamines and arylmethyl amines under aerobic conditions. The methodology has wide substrate scope and tolerates a wide range of functional groups affording the products in high yields. The use of arylethyl amines instead of arylmethyl amines gives 2-aryl quinoxalines.

  据报道，通过有氧条件下邻苯二胺与芳基甲基胺的反应，可见光促进了2-芳基苯并咪唑的多米诺骨牌合成。该方法具有广泛的底物范围，并且可以耐受多种官能团，从而以高收率提供了产品。使用芳基乙基胺代替芳基甲基胺得到2-芳基喹喔啉。
• Building Heterocyclic Systems with RC(OR)2+ Carbocations in Recyclable Brønsted Acidic Ionic Liquids: Facile Synthesis of 1-Substituted 1H-1,2,3,4-Tetrazoles, Benzazoles and Other Ring Systems with CH(OEt)3 and EtC(OEt)3 in [EtNH3][NO3] and [PMIM(SO3H)][O
  作者：Gopalakrishnan Aridoss、Kenneth K. Laali

  DOI：10.1002/ejoc.201100128

  日期：2011.5

  IL-1/CH(OEt) 3 . The latter was also formed from 2-aminobenzoic acid in IL-1/CH(OEt) 3 . Mechanistic implications are addressed. The reported protocols enable rapid assembly of a host of heterocyclic systems in high yields with the added advantage of recycling and reuse of the ILs.

  1-芳基/烷基-1H-1,2,3,4-四唑可以通过与TMSN 3 和CH(OEt) 3 反应，使用容易获得的、可回收的、布朗斯台德酸性从相应的胺在一锅反应中方便地合成离子液体 [EtNH 3] -[NO 3 ] IL-1 和 [PMIM(SO 3 H)][OTf] IL-2 在温和条件下以高收率。基于对比反应，虽然两种 IL 都是极好的促进剂，但使用 IL-2 可以在更短的反应时间和更高的产率下完成反应。在提供的 24 个实施例中，除了 2-氨基苯甲酸与 IL-2 形成四唑和 IL-1 形成 2-乙基喹唑啉-4(3H)-one 外，通过两种 IL 获得了相同的产物。通过从反应中排除 TMS-N 3，原位形成的 CH(OEt) 2 + 和 Et-C(OEt) 2 +（通过它们相应的原酸酯）在超声处理下与带有各种取代基的邻苯二胺、邻氨基苯硫酚和邻氨基苯酚反应，形成一系列广泛的苯并咪唑（苯并咪唑
• [EN] PHOSPHOGLYCERATE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PHOSPHOGLYCÉRATE KINASE
  申请人：ABBOTT LAB

  公开号：WO2012045196A1

  公开（公告）日：2012-04-12

  Disclosed are compounds of formula (I) or pharmaceutical acceptable salts thereof, wherein R1, R2, R3 and R4 are as defined in the description. Disclosed are also the methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as phosphoglycerate kinase.

  揭示了化合物的结构式（I）或其药用可接受的盐，其中R1、R2、R3和R4如描述中所定义。还公开了制备所述化合物的方法，以及含有这些化合物的组合物，这些化合物对抑制磷酸甘油酸激酶等激酶具有用处。
• Catalyst-free ambient temperature synthesis of isoquinoline-fused benzimidazoles from 2-alkynylbenzaldehydes <i>via</i> alkyne hydroamination
  作者：Manisha Mishra、Dylan Twardy、Clifford Ellstrom、Kraig A. Wheeler、Roman Dembinski、Béla Török

  DOI：10.1039/c8gc02520g

  日期：——

  route for the synthesis of benzimidazo[2,1-a]isoquinoline has been developed by reacting 2-ethynylbenzaldehyde and related substituted alkynylbenzaldehydes with variously substituted ortho-phenylenediamines and aliphatic amines in ethanol. This method provides a convenient, room temperature, atom-economical, and catalyst-free access to diversely substituted isoquinoline fused benzimidazoles. Regioselectivity

  通过使2-乙炔基苯甲醛和相关的取代的炔基苯甲醛与各种取代的邻苯二胺和脂肪族胺在乙醇中反应，已开发出一种用于合成苯并咪唑并[ 2,1- a ]异喹啉的有效的环境友好途径。该方法提供了一种方便，室温，原子经济且无催化剂的方法，可轻松获得各种取代的异喹啉稠合的苯并咪唑类化合物。通过X射线晶体学证实了该反应的区域选择性，称为邻苯二胺。发现该反应发生在三个主要步骤（亚胺形成，环化和芳构化）中，并提出了一种机理。